Delta in the real world

Delta has proven that combination nucleoside therapy is modestly superior to zidovudine monotherapy for patients with HIV, and that benefit is greater in zidovudine-naive patients than in zidovudine-experienced patients. The clinical trials involving zidovudine are discussed.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet (British edition) 1996-08, Vol.348 (9023), p.278-279
1. Verfasser:	Sherer, Renslow
Format:	Artikel
Sprache:	eng
Schlagworte:	Acquired Immunodeficiency Syndrome - prevention & control AIDS/HIV Antiviral Agents - administration & dosage Clinical trials Clinical Trials as Topic Drug therapy Drug Therapy, Combination Female HIV HIV Infections - drug therapy Human immunodeficiency virus Humans Physician's Role Pregnancy Zidovudine - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Delta has proven that combination nucleoside therapy is modestly superior to zidovudine monotherapy for patients with HIV, and that benefit is greater in zidovudine-naive patients than in zidovudine-experienced patients. The clinical trials involving zidovudine are discussed.
ISSN:	0140-6736 1474-547X
DOI:	10.1016/S0140-6736(05)64466-2